D.A. Davidson & Co.
- SEC CIK
- 0001080107
- Latest filing
- Jul 24, 2026
EW holding history
Edwards Lifesciences Corp in every 13F filed by D.A. Davidson & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EW overviewAll 13F holders of EWFull Q2 2026 holdings
- Shares (Q2 2026)
- 11,091
- Value
- $1.00M
- % of portfolio
- <0.1%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 11,091 | $1.00M | <0.1% | −325−2.8% | Reduced | Holders |
| Q1 2026 | 11,416 | $914.2K | <0.1% | +622+5.8% | Added | Holders |
| Q4 2025 | 10,794 | $920.2K | <0.1% | +732+7.3% | Added | Holders |
| Q3 2025 | 10,062 | $782.5K | <0.1% | +831+9.0% | Added | Holders |
| Q2 2025 | 9,231 | $722.0K | <0.1% | −82−0.9% | Reduced | Holders |
| Q1 2025 | 9,313 | $675.0K | <0.1% | −720−7.2% | Reduced | Holders |
| Q4 2024 | 10,033 | $742.7K | <0.1% | +300+3.1% | Added | Holders |
| Q3 2024 | 9,733 | $642.3K | <0.1% | −17,356−64.1% | Reduced | Holders |
| Q2 2024 | 27,089 | $2.50M | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 27,089 | $2.59M | <0.1% | −1,950−6.7% | Reduced | Holders |
| Q4 2023 | 29,039 | $2.21M | <0.1% | −13,681−32.0% | Reduced | Holders |
| Q3 2023 | 42,720 | $2.96M | <0.1% | +562+1.3% | Added | Holders |
| Q2 2023 | 42,158 | $3.98M | <0.1% | +344+0.8% | Added | Holders |
| Q1 2023 | 41,814 | $3.42M | <0.1% | −3,001−6.7% | Reduced | Holders |
| Q4 2022 | 44,815 | $3.37M | <0.1% | −5,109−10.2% | Reduced | Holders |
| Q3 2022 | 49,924 | $4.18M | 0.1% | −1,091−2.1% | Reduced | Holders |
| Q2 2022 | 51,015 | $4.85M | 0.1% | −216−0.4% | Reduced | Holders |
| Q1 2022 | 51,231 | $6.03M | 0.1% | +322+0.6% | Added | Holders |
| Q4 2021 | 50,909 | $6.65M | 0.1% | −1,672−3.2% | Reduced | Holders |
| Q3 2021 | 52,581 | $5.95M | 0.1% | −200.0% | Reduced | Holders |
| Q2 2021 | 52,601 | $5.45M | 0.1% | −1,375−2.5% | Reduced | Holders |
| Q1 2021 | 53,976 | $4.51M | 0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.